Disparities in the access to immune checkpoint inhibitors approved in the United States, the European Union and mainland China: a serial cross-sectional study

Background Immune checkpoint inhibitors (ICIs) have revolutionised antitumour therapy. However, regional differences in ICI labels, including the impact of the review process and supporting trial evidence, remain unclear.Methods We conducted a serial cross-sectional study to examine trends and diffe...

Full description

Bibliographic Details

Published in:	BMJ Public Health
Main Authors:	Jin-Ling Tang, Hao Hu, Carolina Oi Lam Ung, Shi-Yu Wang, Jia-Xin Cai, Fu-Xiao Li, Teng-Fei Lin, Shi-Fu Luo, Hai-Bo Song, Zhi-Rong Yang, Wei-Hua Meng
Format:	Article
Language:	English
Published:	BMJ Publishing Group 2025-05-01
Online Access:	https://bmjpublichealth.bmj.com/content/3/1/e001995.full